Profile of:

Carla Gonçalves Schahin Saad

Full name: Carla Gonçalves Schahin Saad

Current country: Brazil

Membership level: Full

Type of membership: Member

Number of publications: 13

Immunogenicity and safety of two doses of the CoronaVac SARS-CoV-2 vaccine in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic diseases in Brazil: a subgroup analysis of a phase 4 prospective study (2022)

Effect of an exercise bout before the booster dose of an inactivated SARS-CoV-2 vaccine on immunogenicity in immunocompromised patients (2022)

Increment of immunogenicity after third dose of a homologous inactivated SARS-CoV-2 vaccine in a large population of patients with autoimmune rheumatic diseases (2022)

Interaction of TNFi and conventional synthetic DMARD in SARS-COV-2 vaccine response in axial spondyloarthritis and psoriatic arthritis (2022)

Brazilian recommendations for the use of nonsteroidal anti-inflammatory drugs in patients with axial spondyloarthritis (2021)

Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trial (2021)

Brazilian Society of Rheumatology 2020 guidelines for psoriatic arthritis (2021)

Improvement of conjunctival cytological grade and tear production in Ankylosing Spondylitis patients under TNF inhibitors (2020)

The Brazilian Society of Rheumatology guidelines for axial spondyloarthritis – 2019 (2020)

Ankylosing spondylitis and psoriatic arthritis: revisiting screening of latent tuberculosis infection and its follow-up during anti-tumor necrosis factor therapy in an endemic area (2020)

Assessing bone impairment in ankylosing spondylitis (AS) using the trabecular bone score (TBS) and high-resolution peripheral quantitative computed tomography (HR-pQCT) (2019)

Factors associated with ASDAS remission in a long-term study of ankylosing spondylitis patients under tumor necrosis factor inhibitors (2018)

Monocytes from male patients with ankylosing spondylitis display decreased osteoclastogenesis and decreased RANKL/OPG ratio (2018)